Published in Cancer on August 01, 1995
Preoperative carcinoembryonic antigen is related to tumour stage and long-term survival in colorectal cancer. Br J Cancer (1998) 0.99
Revisiting tumour aneuploidy - the place of ploidy assessment in the molecular era. Nat Rev Clin Oncol (2015) 0.87
DNA index and S-phase fraction in curative resection of colorectal adenocarcinoma: analysis of prognosis and current trends. World J Surg (2002) 0.77
Stage-specific frequency and prognostic significance of aneuploidy in patients with sporadic colorectal cancer--a meta-analysis and current overview. Int J Colorectal Dis (2015) 0.75
Delay in diagnosis and treatment of symptomatic colorectal cancer. Lancet (1979) 4.91
Randomised, controlled trial of faecal occult blood screening for colorectal cancer. Results for first 107,349 subjects. Lancet (1989) 4.72
A classification of fistula-in-ano. Br J Surg (1976) 4.09
Controlled trial of faecal occult blood testing in the detection of colorectal cancer. Lancet (1983) 3.99
Measurement of gastrointestinal pH profiles in normal ambulant human subjects. Gut (1988) 3.14
Clinicopathological staging for colorectal cancer: an International Documentation System (IDS) and an International Comprehensive Anatomical Terminology (ICAT). J Gastroenterol Hepatol (1991) 2.83
The risks of screening: data from the Nottingham randomised controlled trial of faecal occult blood screening for colorectal cancer. Gut (1999) 2.53
Effect of faecal occult blood screening on mortality from colorectal cancer: results from a randomised controlled trial. Gut (2002) 2.50
Surgical emergencies and manpower. Ann R Coll Surg Engl (1984) 2.48
Study of large bowel peristalsis. Gut (1968) 2.34
The influence of tumour cell DNA abnormalities on survival in colorectal cancer. Br J Surg (1985) 2.20
Ambulatory monitoring of oesophageal pH in reflux oesophagitis using a portable radiotelemetry system. Gut (1982) 2.19
Taurolidine peritoneal lavage as prophylaxis against infection after elective colorectal surgery. Br J Surg (1994) 2.18
The results of 1115 patients with colorectal cancer treated over an 8-year period in a single hospital. Eur J Surg Oncol (1985) 2.03
Length of Barrett's oesophagus: an important factor in the development of dysplasia and adenocarcinoma. Gut (1992) 1.96
Radioimmunodetection of human colorectal cancers by an anti-tumour monoclonal antibody. Lancet (1982) 1.71
Ki-ras mutations in adenomas: a characteristic of cancer-bearing colorectal mucosa. J Pathol (1996) 1.70
Cost-effective screening strategies for colorectal cancer. J Public Health Med (1992) 1.67
Nottingham trial of faecal occult blood testing for colorectal cancer: a 20-year follow-up. Gut (2011) 1.67
Risks, costs, and compliance limit colorectal adenoma surveillance: lessons from a randomised trial. Gut (2001) 1.63
Clinical and economic consequences of wound sepsis after appendicectomy and their modification by metronidazole or povidone iodine. Lancet (1981) 1.57
Physical factors in the stimulation of colonic peristalsis. Gut (1970) 1.57
Randomized double-blind phase II survival study comparing immunization with the anti-idiotypic monoclonal antibody 105AD7 against placebo in advanced colorectal cancer. Br J Cancer (2001) 1.56
Two phase III trials of tauromustine (TCNU) in advanced colorectal cancer. Ann Oncol (1995) 1.53
Factors affecting compliance with screening for colorectal cancer. Community Med (1984) 1.52
Faecal occult blood screening for colorectal cancer: is it cost-effective? Health Econ (1998) 1.51
Screening for colorectal cancer with an immunological faecal occult blood test: 2-year follow-up. Br J Surg (1996) 1.49
Screening for symptomless colorectal cancer by testing for occult blood in general practice. Lancet (1980) 1.48
Clinical and radiographic features of simple and hydatid cysts of the liver. Br J Surg (1986) 1.47
A frequency-duration index (FDI) for the evaluation of ambulatory recordings of gastro-oesophageal reflux. Br J Surg (1984) 1.45
Bile reflux in columnar-lined Barrett's oesophagus. Ann R Coll Surg Engl (1993) 1.44
Screening and the costs of treating colorectal cancer. Br J Cancer (1993) 1.44
Acute non-tuberculous psoas abscess. Report of 10 cases and review of the literature. Br J Surg (1970) 1.42
Fecal occult blood screening for colorectal cancer in the general population. Results of a controlled trial. Cancer (1986) 1.40
Flexible fiberoptic sigmoidoscopy and double-contrast barium-enema examination in the identification of adenomas and carcinoma of the colon. Dis Colon Rectum (1983) 1.39
Predeposit autologous blood transfusion in patients with colorectal cancer: a feasibility study. Br J Surg (1992) 1.39
Early diagnosis of colorectal cancer: a review. J R Soc Med (1984) 1.37
Subcuticular suturing after appendicectomy. Lancet (1977) 1.32
Interval cancers in a randomized controlled trial of screening for colorectal cancer using a faecal occult blood test. Int J Epidemiol (1999) 1.29
An evaluation of flexible fibreoptic sigmoidoscopy. Br Med J (Clin Res Ed) (1981) 1.28
Inhibition of organ invasion by the matrix metalloproteinase inhibitor batimastat (BB-94) in two human colon carcinoma metastasis models. Cancer Res (1995) 1.27
Gastrointestinal intraluminal pH in normal subjects and those with colorectal adenoma or carcinoma. Gut (1990) 1.22
The action of sennosides and related compounds on human colon and rectum. Gut (1970) 1.22
Comparison of rigid and flexible fibreoptic sigmoidoscopy with double contrast barium enemas. Br J Surg (1982) 1.21
Randomized trial of the addition of flexible sigmoidoscopy to faecal occult blood testing for colorectal neoplasia population screening. Br J Surg (1997) 1.21
Use of glyceryl trinitrate ointment in the treatment of anal fissure. Br J Surg (1996) 1.20
Transanal endoscopic microsurgery--initial experience from three centres in the United Kingdom. Br J Surg (1996) 1.20
Bleeding patterns in colorectal cancer: the effect of aspirin and the implications for faecal occult blood testing. Br J Surg (1982) 1.20
Assessment of proliferation of squamous, Barrett's and gastric mucosa in patients with columnar lined Barrett's oesophagus. Gut (1992) 1.20
Accuracy of occult blood tests over a six-day period. Clin Oncol (1983) 1.19
Colorectal screening by a self-completion questionnaire. Gut (1984) 1.19
A comparison of an immunological faecal occult blood test Fecatwin sensitive/FECA EIA with Haemoccult in population screening for colorectal cancer. Br J Cancer (1985) 1.19
Colorectal cancer, screening and survival: the influence of socio-economic deprivation. Public Health (2003) 1.18
Effect of histamine on the growth of human gastrointestinal tumours: reversal by cimetidine. Gut (1993) 1.16
Gastrimmune raises antibodies that neutralize amidated and glycine-extended gastrin-17 and inhibit the growth of colon cancer. Cancer Res (1996) 1.15
A comparison of methods for increasing compliance within a general practitioner based screening project for colorectal cancer and the effect on practitioner workload. J Epidemiol Community Health (1988) 1.15
Enhanced cell-mediated tumor killing in patients immunized with human monoclonal antiidiotypic antibody 105AD7. Cancer Res (1994) 1.15
Antitumor immune response and interleukin 2 production induced in colorectal cancer patients by immunization with human monoclonal anti-idiotypic antibody. Cancer Res (1991) 1.14
Clinical outcome of colorectal cancer patients treated with human monoclonal anti-idiotypic antibody. Int J Cancer (1994) 1.13
A prospective multicenter evaluation of new fecal occult blood tests in patients undergoing colonoscopy. Am J Gastroenterol (2000) 1.13
Role of upper gastrointestinal investigations in a screening study for colorectal neoplasia. Gut (1990) 1.11
Colon "cast" in a patient with ischaemic colitis. Br J Surg (1987) 1.10
Reflux versus dysphagia: an objective evaluation of the Angelchik prosthesis. Br J Surg (1985) 1.09
Dose beta-blockade affect surgical performance? a double blind trial of oxprenolol. Br J Surg (1980) 1.08
ACPGBI position statement on elective resection for diverticulitis. Colorectal Dis (2011) 1.07
Role of dietary restriction in Haemoccult screening for colorectal cancer. Br J Surg (1989) 1.07
The characteristics of blood-borne radiolabels and the effect of anti-mouse IgG antibodies on localization of radiolabeled monoclonal antibody in cancer patients. J Nucl Med (1985) 1.07
Accuracy of identification of early gastric cancer. Br J Surg (1987) 1.06
Association of antigen expression and DNA ploidy in human colorectal tumors. Cancer Res (1986) 1.06
Enhanced expression of the complement regulatory protein CD55 predicts a poor prognosis in colorectal cancer patients. Cancer Immunol Immunother (2003) 1.04
Immunohistochemical localization of Y hapten and the structurally related H type-2 blood-group antigen on large-bowel tumours and normal adult tissues. Int J Cancer (1984) 1.04
Imaging of pancreatic and colorectal cancer using antibody fragments: a preliminary evaluation. Eur J Surg Oncol (1988) 1.04
Evaluation of the plain abdominal X-ray in the acute abdomen. J R Soc Med (1985) 1.04
Population screening for colorectal cancer: comparison between guaiac and immunological faecal occult blood tests. Br J Surg (1994) 1.03
Endoscopic review of patients who have had gastric surgery. Br Med J (Clin Res Ed) (1983) 1.03
Detection of colorectal liver metastases using intraoperative ultrasonography. Br J Surg (1991) 1.02
Localisation of human osteosarcoma by antitumour monoclonal antibody. J Bone Joint Surg Br (1983) 1.00
Antigenicity of newly established colorectal carcinoma cell lines. Br J Cancer (1986) 1.00
Partial resection and fenestration in the treatment of polycystic liver disease. Br J Surg (1984) 1.00
Quantitation of MHC antigen expression on colorectal tumours and its association with tumour progression. Br J Cancer (1987) 1.00
Haemoccult screening for colorectal cancer: the effect of dietary restriction on compliance. Eur J Surg Oncol (1994) 1.00
Psychiatric morbidity and screening for colorectal cancer. J Med Screen (2002) 1.00
Preoperative carcinoembryonic antigen is related to tumour stage and long-term survival in colorectal cancer. Br J Cancer (1998) 0.99
Can albendazole reduce the risk of implantation of spilled protoscoleces? An animal study. Trans R Soc Trop Med Hyg (1986) 0.98
Colorectal adenomas and energy intake, body size and physical activity: a case-control study of subjects participating in the Nottingham faecal occult blood screening programme. Br J Cancer (1993) 0.98
Screening of average-risk individuals for colorectal cancer. WHO Collaborating Centre for the Prevention of Colorectal Cancer. Bull World Health Organ (1990) 0.98
The descending perineum syndrome. Practitioner (1969) 0.98
Effects of neostigmine and atropine on motor activity of ileum, colon, and rectum of anaesthetized subjects. Br Med J (1970) 0.97
Hepatic perfusion index in the diagnosis of overt metastatic colorectal cancer. Nucl Med Commun (1990) 0.97
The localization of an anti-tumour monoclonal antibody (791T/36) in gastrointestinal tumours. Br J Surg (1984) 0.97